A new interactive map of the surface of SARS-CoV-2, featuring the Spike, Envelope and Membrane proteins, has been released for researchers to use.
List view / Grid view
Filter the results
24 September 2020 | By PerkinElmer
.Join us on 12 November for our live webinar were two leading researchers will discuss their innovative approaches to developing novel opportunities for immunotherapy treatments.
A powerful, yet affordable, high-content imaging system in your own lab.
Scientists have found two active substances that allowed cells to reactivate the production of a protein that prevents the onset of Parkinson's disease.
A new tool called COVID-3D that monitors SARS-CoV-2 genome mutations could aid drug and vaccine development, its creators say.
An analysis of blood protein levels has supported drug target prioritisation by identifying the causal effects of proteins on diseases, a team has shown.
According to a new report, artificial intelligence (AI) is vital for the rapid identification of drugs that can be repurposed to combat COVID-19.
Using TEMPEST®, St. Jude Children’s Research Hospital were able to rapidly screen a focused compound library for early cancer drug candidates in an AlphaLISA® assay.
Researchers have found that the SARS-CoV-2 nucleocapsid protein may help the virus to spread from cell to cell, providing a drug target.
A team has developed a predictive tool called TransComp-R which could be used to reveal whether new drugs that have been effective in animals will have positive outcomes in humans.
A machine learning algorithm that predicts sites of DNA methylation could aid in the identification of disease-causing mechanisms, say researchers.
The third phase of the ENCODE project has been released, with new information on genes and their potential regulators in their respective genomes.